Ninth International Workshop on HIV and Hepatitis Co-infection, Rome, Italy
30 May 2013 - 30 May 2013
Italy
The Ninth International Workshop on HIV and Hepatitis Co-infection will be held from 30 to 31 May 2013 in Rome, Italy.
With the success of antiretroviral therapy, HIV-infected patients are seeing improvement in longevity, only to be challenged with the dangers and complications of additional viral infections. One can get some forms of viral hepatitis the same way he gets HIV. Persons with HIV infection are disproportionately affected by viral hepatitis; about one-third of them being co-infected with hepatitis B or hepatitis C, which can cause long-term (chronic) illness, death and complicate the management of HIV infection. As a result, all persons living with HIV should be tested for hepatitis B and hepatitis C by their doctors.
Depending on the country, these patients can represent a majority or a significant minority of the HIV patients under care. Although HIV/Hepatitis co-infection was a small part of some major HIV conferences, there is a growing need among clinicians and researchers to focus on this challenge.
The workshop will focus on developments in basic science, emerging therapies and clinical management. It will emphasize translational research and best practices in the clinical management of Hepatitis and HIV co-infection.For further information, please visit:
http://www.virology-education.com/index.cfm/t/Welcome/vid/7ACDAA79-A8AA-43A9-7E31FA3544E4CF1B
With the success of antiretroviral therapy, HIV-infected patients are seeing improvement in longevity, only to be challenged with the dangers and complications of additional viral infections. One can get some forms of viral hepatitis the same way he gets HIV. Persons with HIV infection are disproportionately affected by viral hepatitis; about one-third of them being co-infected with hepatitis B or hepatitis C, which can cause long-term (chronic) illness, death and complicate the management of HIV infection. As a result, all persons living with HIV should be tested for hepatitis B and hepatitis C by their doctors.
Depending on the country, these patients can represent a majority or a significant minority of the HIV patients under care. Although HIV/Hepatitis co-infection was a small part of some major HIV conferences, there is a growing need among clinicians and researchers to focus on this challenge.
The workshop will focus on developments in basic science, emerging therapies and clinical management. It will emphasize translational research and best practices in the clinical management of Hepatitis and HIV co-infection.For further information, please visit:
http://www.virology-education.com/index.cfm/t/Welcome/vid/7ACDAA79-A8AA-43A9-7E31FA3544E4CF1B